منابع مشابه
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
Cardiovascular disease is the most severe complication of acromegaly accounting for the increased mortality of these patients. Recently, the slow-release form of octreotide (OCT; Sandostatin LAR, OCT-LAR), for im injection every 28 days, was reported to induce suppression of GH levels below 7.5 mU/L (2.5 microg/L) in 39-75% of patients, and normalization of insulin-like growth factor (IGF)-I le...
متن کاملRheumatoid arthritis associated with the use of Sandostatin® LAR® depot in a patient with pancreatic neuroendocrine tumor. An association or a coincidence? The first case report.
CONTEXT Sandostatin® LAR® depot is a synthetic analogue of the naturally occurring hormone somatostatin and is indicated for certain patients with acromegaly and severe diarrhea and flushing episodes associated with metastatic carcinoid tumors and for the long-term treatment of the profuse watery diarrhea associated with VIP-secreting tumors in patients in whom initial treatment with immediate ...
متن کاملJourney of a patient editor.
Nine years ago the BMJ’s Tessa Richards underwent thoraco-abdominal surgery for adrenal cancer, followed by further surgery to remove metastases. Now the senior editor in charge of the journal’s patient partnership agenda, she reflects on how her own experience of illness and recovery, and of joining the ranks of patients who survive the odds, have shaped her understanding of the patient perspe...
متن کاملLogging The BMJ's "patient journey".
Recognising the crucial role of patients in tackling “corruption in the mission of healthcare,” two years ago The BMJ set up an international patient advisory panel to help us develop a strategy to promote patient partnership. We figured that “walking the talk” in our own editorial processes was the best way to advance change. We launched our strategy last June, and its development is charted o...
متن کاملMicrosoft health patient journey demonstrator.
BACKGROUND As health care becomes more reliant on electronic systems, there is a need to standardise display elements to promote patient safety and clinical efficiency. The Microsoft Health Common User Interface (MSCUI) programme, developed by Microsoft and the National Health Service (NHS) was born out of this need and creates guidance and controls designed to increase patient safety and clini...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2014
ISSN: 1098-3015
DOI: 10.1016/j.jval.2014.03.538